Aptose Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $52,356,000.

Profit Margin

Aptose Biosciences Inc. (NASDAQ:APTO): Profit margin
2014 0 -11.50K
2015 0 -10.53M
2016 0 -13.85M
2017 0 -11.66M
2018 0 -28.86M
2019 0 -25.69M
2020 0 -54.70M
2021 0 -65.26M
2022 0 -41.05M
2023 0 -51.20M

APTO Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000000000
Cost of revenue
474.54K507.07K616.52K646.43K627.25K83.51K89.09K114.83K69.10K0
Gross profit
-474.54K-507.07K-616.52K-646.43K-627.25K-83.51K-89.09K-114.83K-69.10K0
Operating exp.
Research and development
36.76M28.08M45.98M29.28M16.83M18.73M6.27M7.67M4.50M3.55K
Selling and marketing
0000000000
Total operating expenses
52.35M42.60M65.44M55.76M26.85M29.10M11.82M13.88M11.60M11.83K
Operating income
-52.35M-42.59M-65.44M-55.77M-26.86M-29.10M-11.82M-13.88M-11.60M-11.76K
Other income (expenses), net
1.14M770K92K530K586K-44K165K-49.10K1.06M259
Income before tax
-51.20M-41.82M-65.35M-55.23M-26.27M-28.86M-11.66M-13.85M-10.53M-11.50K
Income tax expense
0-770K-93K-530K-580K-44K97K030.98K0
Net income
-51.20M-41.05M-65.26M-54.70M-25.69M-28.86M-11.66M-13.85M-10.53M-11.50K
Earnings per share
Basic EPS
-7.58-6.67-10.99-10.03-7.68-12.97-7.84-16.32-13.29-0.01
Diluted EPS
-7.58-6.67-10.99-10.03-7.68-12.97-7.84-16.31-13.28-0.01
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source